Tactile systems CEO Sheri Dodd sells $323,242 in company stock

Tactile Systems Technology Inc. CEO Sheri Dodd divested $323,242 worth of company stock on August 10, 2026. The stock sale amounted to 10,978 shares, with prices ranging between $28.93 and $29.81 per share, giving a weighted average sale price of $29.4446. The transaction was reportedly to settle taxes from stock unit settlements.

Dodd's remaining shareholding stands at 232,907 shares post-sale. TCMD's stock price has dipped by about 18% over the past week, settling at $24.20, under Dodd's average sale price. However, over the past year, the stock has generated a 95% return. InvestingPro suggests TCMD is underpriced, trading below its Fair Value and boasting a perfect Piotroski Score of 9.

Investors can obtain a full Pro Research Report on TCMD from InvestingPro. Tactile Medical also announced strong Q2 earnings, surpassing Wall Street's expectations with adjusted earnings of $0.34 per share, compared to the estimated $0.17 per share. The company's revenue was $85.7 million, slightly above forecasted figures, with a 9% year-on-year growth.

Gross margin improved to 76.3%, a 180 basis points increase from the previous year. However, the AffloVest business witnessed a 7% year-over-year revenue decline, prompting a more cautious outlook. Tactile Medical adjusted its full-year revenue guidance to $360 million to $366 million, citing stable Medicare coverage but new prior authorization requirements causing operational friction. Analysts and investors are closely monitoring these developments.